e-learning
resources
Virtual 2020
Pre-Congress Content
Experimental approaches to pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mendelian Randomization Study Showed No Causality between Type 2 Diabetes and Pulmonary Hypertension
J. Zhang (Guangzhou, China), J. Liao (Guangzhou, China), Y. Chen (Guangzhou, China), Y. Chen (Guangzhou, China), J. Wang (Guangzhou, China)
Source:
Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Session:
Experimental approaches to pulmonary hypertension
Session type:
E-poster session
Number:
1494
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Zhang (Guangzhou, China), J. Liao (Guangzhou, China), Y. Chen (Guangzhou, China), Y. Chen (Guangzhou, China), J. Wang (Guangzhou, China). Mendelian Randomization Study Showed No Causality between Type 2 Diabetes and Pulmonary Hypertension. 1494
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Association between Metabolites Biomarkers and Pulmonary Hypertension:A Mendelian Randomization analysis
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Effects of Telerehabilitation on Dyspnea and Exercise Capacity in Patients with Type 2 Diabetes Mellitus Who Smoked.
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017
Type 2 Diabetes Acentuates the Impairment in the Lung Function and Mechanics in Elderly
Source: Virtual Congress 2020 – Advances in lung function practice
Year: 2020
Responses to Two Different High-Intensity Interval Exercise Training Protocols on Pulmonary Function and Respiratory Muscle Strength In Diabetes Mellitus
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021
Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Pulmonary Hypertension in Childhood
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020
Clinical Features of Pulmonary Hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012
Clinical Characteristics and Outcomes of Type 2 Diabetes and patients Infected with COVID-19
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Risk Factors Associated to Cardiovascular Events after Bronchiectasis Exacerbation: A Prospective Study.
Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Year: 2020
Increased Risk of Heart Failure In Patients of Bronchiectasis – A Nationwide Population-Based Study
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019
Sarcoidosis-associated Pulmonary Hypertension: A London Cohort
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Risk Score for Subclinical COPD: The NHLBI Pooled Cohorts Study
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020
Disease Burden and Unmet Need in Asthma with Type 2 Inflammation
Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics
Year: 2017
Study on prevalence and associated factors of Diabetes Mellitus among Tuberculosis Patients in Iran
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COvid-19 Interstitial Lung Syndrome (PCOILS)
Source: Virtual Congress 2021 – Imaging
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept